|
Ya.V. Girsh, O.A. Veliyeva
SAFE AND EFFECTIVE COMBINATION OF ULTRALONG-ACTING BASAL INSULIN DEGLUDEC AND ULTRA-SHORT ACTING INSULINE ASPART IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
|
8-13 |
|
N.A. Demidov (1), M.B. Antsiferov (2), L.G. Dorofeeva (2)
EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE
|
14-20 |
|
E.V. Biryukova
SELF-CONTROL OF GLYCEMIA: SHELFLIFE OF TEST STRIPS IS IMPORTANT
|
21-27 |
|
A.S. Ametov
PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS
|
28-35 |
|
E.V. Biryukova
MODERN OPPORTUNITIES OF BONE ANABOLIC THERAPY OF OSTEOPOROSIS
|
36-42 |
|
M.E. Telnova, N.A. Petunina
BISPHOSPHONATES IN THE TREATMENT OF OSTEOPOROSIS. EFFICACY AND SAFETY OF IBANDRONATE
|
43-47 |
|
M.B. Antsiferov (1), V.S. Pronin (2)
STRATEGY OF ACTIVE SEARCH FOR PATIENTS WITH ACROMEGALY: CASE REPORT
|
48-50 |
|
I.B. Zhurtova
THE CHOICE OF TACTICS OF TREATMENT OF GIANT RETROSTERNAL DIFFUSE TOXIC GOITER IN ELDERLY AGE
|
51-55 |
|
I.T. Murkamilov (1), K.A. Aytbaev (2), F.A. Yusupov (3)
ANGIOTENSIN II RECEPTOR BLOCKERS AND ENDOTHELIAL DYSFUNCTION: FOCUS ON NEPHROCEREBRAL INTERACTIONS
|
56-59 |
|
A.F. Verbovoy, L.A. Sharonova, A.V. Pashentseva, I.A. Tsanava
INSULIN RESISTANCE SYNDROME IN THE CLINIC OF INTERNAL DISEASES
|
60-67 |
|
L.A. Sharonova, A.F. Verbovoy, I.A. Tsanava
STATE OF CARDIOVASCULAR SYSTEM IN METABOLIC SYNDROME
|
68-74 |
|
N.A. Petunina, A.L. Terekhova
ELDERLY PATIENT WITH TYPE 2 DIABETES MELLITUS: FOCUS ON ALOGLIPTIN
|
75-81 |
|
I.A. Baranova
ALFACALCIDOL IN TREATMENT OF OSTEOPOROSIS
|
82-85 |
|
N.A. Chernikova
CURRENT POSSIBILITIES OF COMBINED THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
|
86-90 |
|
A.F. Verbovoy, Yu.A. Dolgikh, O.V. Kosareva, L.A. Sharonova, I.A. Tsanava
INSULIN RESISTANCE AND THYROID HORMONES
|
91-95 |
Русский
